Suppr超能文献

[微小小梁假体在难治性青光眼手术中的疗效]

[The efficacy of a microtrabecular prosthesis in the surgery of refractory glaucomas].

作者信息

Chiseliţă D, Drănişteanu D

机构信息

Clinica Oftalmologică Iaşi.

出版信息

Oftalmologia. 1995 Oct-Dec;39(4):322-32.

PMID:7577902
Abstract

A new model of intermediate artificial drainage system (called microtrabeculoprosthesis--MTP) in the surgery of refractory glaucoma is suggested. The prospective study includes 37 operated cases followed up for an average interval of 18.2 months (ranges 11 and 72 months). Surgery is not difficult, and MTP is very well tolerated. A relief of elevated intraocular pressure (IOP < or = 20 mm Hg) was obtained in 73% of the cases (with or without additional antiglaucoma drugs); the irritative phenomena have disappeared in preterminal and absolute glaucoma; the overall therapeutic success rate was 86.5%. The results obtained with MTP are definitely superior to those by conventional surgery but inferior to modern posterior artificial drainage systems (with ameliorative techniques); the rate of postoperative complications is small, and their severity is minimal. In the absence of modern posterior artificial drainage systems. MTP is an efficient solution for the treatment of refractory glaucoma.

摘要

提出了一种用于难治性青光眼手术的新型中间人工引流系统模型(称为微小梁假体——MTP)。前瞻性研究纳入了37例手术病例,平均随访间隔为18.2个月(范围为11至72个月)。手术并不困难,且MTP耐受性良好。73%的病例眼压得到缓解(眼压≤20 mmHg,无论是否使用其他抗青光眼药物);在晚期和绝对期青光眼中,刺激症状消失;总体治疗成功率为86.5%。MTP所获得的结果明显优于传统手术,但不如现代后部人工引流系统(采用改良技术);术后并发症发生率低,严重程度也最小。在没有现代后部人工引流系统的情况下,MTP是治疗难治性青光眼的有效解决方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验